NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts (Q33932080)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts |
scientific article |
Statements
1 reference
NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts (English)
1 reference
Louis J Ignarro
1 reference
Karuppaiyah Selvendiran
1 reference
Anna Bratasz
1 reference
Liyue Tong
1 reference
Periannan Kuppusamy
1 reference
28 September 2007
1 reference
1 reference
81-88
1 reference
Identifiers
1 reference
1 reference
1 reference